text.skipToContent text.skipToNavigation
  • /medias/default-supplier-banner-2.jpg?context=bWFzdGVyfHJvb3R8MzAyODU5fGltYWdlL2pwZWd8YUdKbEwyZzVOUzg1TnpNM016VTFPVFV5TVRVNEwyUmxabUYxYkhRdGMzVndjR3hwWlhJdFltRnVibVZ5TFRJdWFuQm58YTAxNGVjODAzZjhkMjUxOWI2Nzk3YjhiZDkwN2ZlMzI1YzdmYjViYjdlYjc5YmRiOTA4MWVhYTczZDk1MTBjOQ
Applied FiltersClear all

Country

Switzerland (1)

Category

Pharmaceutical Ingredients (1)

Sub Category

API (1)

Application

Antineoplastic (1)

Supplier

DKSH (1)

Physical Form

Solid (1)

Function

Proteasome inhibitor (1)

Certification

DMF (1)

Sustainable

false (1)

Close Filter

DKSH

We have found 1 items.

Filter
Applied FiltersClear all

Category

Pharmaceutical Ingredients (1)

Sub Category

API (1)

Application

Antineoplastic (1)

Physical Form

Solid (1)

Function

Proteasome inhibitor (1)

Certification

DMF (1)

Sustainable

false (1)

Close Filter
Sample Request
Requestor's contact details
Full name
Company
Position
Telephone number
Work email address
Shipping address
Submit

Thank you. Your request has been sent.

Carfilzomib

Carfilzomib is an anti-cancer drug acting as a selective proteasome inhibitor. Chemically, it is a tetrapeptide epoxyketone and an analog of epoxomicin. 
Quote request
Product quantity has been updated.